Umlaut.bio
ID: 945669Umlaut.bio is a developer of tRNA-modifying small molecules founded in 2024 by Bastian Linder.
1
Funding Rounds
$3.5m
Money raised
Recent Funding Rounds
Overview
Umlaut.bio is a developer of tRNA-modifying small molecules founded in 2024 by Bastian Linder.
- Website:
- Headquarters: Zürich
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ba***** Li**** |
|
- | |
| Ka***** Fi***** |
|
- |
Funding series
Funding Series Analysis
The company Umlaut.bio has raised a total of $3.5m in funding over 1 rounds.
Key Insights:
- Umlaut.bio Pre-Seed Round, February 2026: $3.5m